Mycophenolate Mofetil Tablet Generics bulk supplier for pharma manufacturers

Mycophenolate Mofetil Tablet Generics 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 250 mg, 500 mg

Reference Brands: CellCept® (US and EU), Myfortic® (US and EU)

Mycophenolate Mofetil Tablets are immunosuppressive medications used in nephrology to prevent organ rejection in kidney transplant patients.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Mycophenolate Mofetil Tablet Generics? List it or send an offer →

Product Description:

Mycophenolate Mofetil Tablets are immunosuppressive medications widely used in nephrology to prevent organ rejection in kidney transplant patients. This effective medication works by inhibiting immune system cells, thereby reducing the risk of transplant rejection. Marketed under leading brands such as CellCept® (US and EU) and Myfortic® (US and EU), Mycophenolate Mofetil is available in tablet form and is often used in combination with other immunosuppressants like cyclosporine and prednisone. It is essential for managing transplant patients' health and ensuring long-term graft survival. Pharma B2B buyers can rely on Mycophenolate Mofetil for high-quality, trusted nephrology solutions.

Mycophenolate Mofetil Tablet Generics — third party manufacturing & bulk supply

Mycophenolate Mofetil Tablet Generics 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Mycophenolate Mofetil Tablet Generics is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Mycophenolate Mofetil Tablet Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Mycophenolate Mofetil Tablet Generics →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Mycophenolate Mofetil Tablet Generics is listed as Tablet in 250 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Mycophenolate Mofetil Tablet Generics is referenced against CellCept® (US and EU), Myfortic® (US and EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.